PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE IV

This adverse event was reported 45 times

These drugs are most commonly taken by patients reporting PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE IV:

# Drug Count
0 PREDNISOLONE 29
1 PREDNISOLONE ORAL 29
2 PREDNISOLONE ORAL SOLUTION 29
3 CYCLOPHOSPHAMIDE 16
4 CYCLOPHOSPHAMIDE FOR INJECTION 16
5 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 16
6 ACYCLOVIR 10
7 AMPHOTERICIN B 10
8 APIXABAN 10
9 AZATHIOPRINE 10
See all common drugs associated with PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE IV

PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ROMIDEPSIN 3 0.0018
1 CHLORAMBUCIL 6 0.0015
2 AMPHOTERICIN B 10 0.0008
3 OFATUMUMAB 10 0.0003
4 TORSEMIDE 10 0.0003
5 PREDNISOLONE ORAL SOLUTION 29 0.0002
6 APIXABAN 10 0.0001
7 METOCLOPRAMIDE HYDROCHLORIDE 10 0.0001
8 AZATHIOPRINE 10 0.0001
9 BRENTUXIMAB VEDOTIN 1 0.0001
See all drugs enriched for association with PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE IV